NANOVIRICIDES, INC. — Revenue by Fiscal Year
4 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/9247e3ba-5b21-4a08-ad4a-bd60050ec0df/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $0 | 2024-07-01 – 2025-06-30 | evidence 0001104659-25-094527 |
| FY 2024 | $0 | 2023-07-01 – 2024-06-30 | evidence 0001410578-24-001650 |
| FY 2023 | $0 | 2022-07-01 – 2023-06-30 | evidence 0001410578-23-002146 |
| FY 2011 | $0 | 2005-05-12 – 2012-03-31 | evidence 0001144204-12-030837 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
NANOVIRICIDES, INC. — all facts · Net Income · Operating Income